Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. - Wikidata - wikimedia - TriplyDB

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

http://www.wikidata.org/entity/Q37036090

about

Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease Targeting neural precursors in the adult brain rescues injured dopamine neurons Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in Urology Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies Myeloid Dendritic Cells are Potential Players in Human Neurodegenerative Diseases Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice Are Microglial Cells the Regulators of Lymphocyte Responses in the CNS?Neuroinflammation in Parkinson's disease and its potential as therapeutic target Relevance of chronic stress and the two faces of microglia in Parkinson's disease Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Viruses and neurodegeneration Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?The dopaminergic system in autoimmune diseases Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity Microglia development and function Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease.Protective Role of Fas-FasL Signaling in Lethal Infection with Herpes Simplex Virus Type 2 in Mice Parkinson's disease and immune system: is the culprit LRRKing in the periphery?Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging Protective Microglia and Their Regulation in Parkinson's Disease Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain Regulation of LRRK2 expression points to a functional role in human monocyte maturation Mechanisms underlying inflammation in neurodegeneration Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention Potential future neuroprotective therapies for neurodegenerative disorders and stroke.Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.

P2860

Q21284512-209BE2F2-C478-4A8F-8D3E-665C6A7D3E6D Q24629942-6C810D9C-AE24-414F-81AE-720EDC930181 Q24646096-BD7C24C7-4093-4228-A772-AB44BC8427F1 Q26745684-CEA0D8D8-18F6-4A88-973D-7EE1CC339E14 Q26767289-67F4B3BC-F2E8-4289-A186-5764798AAA92 Q26770676-1385C4B6-1B32-4D45-8826-293573EAFAEA Q26773064-41B7484E-72F2-4F29-B179-94BD9D1554B8 Q26774826-B6C197E5-0E7E-4BC5-B22C-6E02A00A322B Q26783305-562300C6-D56C-4803-9AA6-707F1371E780 Q26796241-36288FAF-DFCC-4BDA-9917-2D2CB1944EE6 Q26830954-FC4D2733-A8FD-4BBE-8CF1-174792C2A87D Q26849232-2E56E155-8502-4D82-B7D9-4EA054BE18D3 Q26859072-19F3D794-E830-46B4-B7BB-E0FDD7ABE497 Q26861263-A195A7CB-5839-4A86-A422-40F4A2ABD350 Q26991740-B823AAAB-B535-4055-8781-666B335B6ECA Q27015811-5AFDBA5F-A4A3-4CAB-9FC7-1695CD1095EE Q27022728-99742242-C88E-48F2-B4D9-908CC51C7D7E Q27023885-134CDCAB-1CAF-4285-AD8B-5797AF6842E3 Q27027973-198D6F43-2B7C-4FE0-8AD8-B82D6B6B8028 Q27316453-ADB7D401-40B1-48EA-848A-2584A9A69C28 Q27317159-667CE65F-D3B5-42BD-AE44-741032B4E17F Q27324500-A6EB3B0B-D927-4E83-981B-677B95E6969B Q27490311-EF44673B-487F-4A0A-8812-70CEB0A0B107 Q27687171-4F41A9AB-6664-40C2-8CD9-6AEF8D632EFB Q28077869-2AF09811-D2D8-41CE-9683-873945ECAA42 Q28079731-A4FD4627-8460-48D5-8718-CE55B1464F4A Q28391762-75DCB6CD-AFAC-4AB3-8060-4B04EA66F1E8 Q28397422-3E270726-AC71-467D-BCEC-DB39BE5F4944 Q28478382-274C19F6-8898-453F-819F-C614B4C4E3E5 Q28743193-319DB241-F628-40F9-9E99-FBA51AF2F5E9 Q29617977-504748D3-8C7E-48E0-A5E3-2AB172355879 Q31109638-3C00013E-A1A3-4CB3-A619-7DAEA4578B51 Q33526342-31FCF6FE-AD21-4264-AA86-484AFD3D3CA2 Q33553317-6070C139-5B47-42CD-93E9-58E0F89E62A7 Q33603263-C05D8E2C-2396-430D-B0C2-38E0E53EB06F Q33625527-DD488E3D-72BB-4EAC-920D-8EA38E2D5BFF Q33663970-DADC99E2-F8B4-4DB8-A0AA-ED755E6BCB63 Q33687436-F1A40E77-B4BD-4DA7-986E-65FA5A3A0EFD Q33771694-F5D000EB-0F76-4B88-88F7-02AFAF332225 Q33815568-4EC46460-B6C4-4134-A6B4-C8FE9BE0E6A4

P2860

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

http://www.wikidata.org/entity/Q37036090

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Infiltration of CD4+ lymphocyt ...... se model of Parkinson disease.

@en

Infiltration of CD4+ lymphocyt ...... se model of Parkinson disease.

@nl

type

label

Infiltration of CD4+ lymphocyt ...... se model of Parkinson disease.

@en

Infiltration of CD4+ lymphocyt ...... se model of Parkinson disease.

@nl

prefLabel

Infiltration of CD4+ lymphocyt ...... se model of Parkinson disease.

@en

Infiltration of CD4+ lymphocyt ...... se model of Parkinson disease.

@nl

P1433

Q37036090-7D991530-188E-437C-8202-C8EF15B348BF

P1476

Q37036090-B22D2B62-B4B5-4901-86FC-ECF04DEF122E

P2093

Q37036090-06CFEA09-FEB1-4D35-A4EC-76DEC632BD03

Q37036090-0C7811BE-12D0-4E8E-9AFB-EF94F0F227EF

Q37036090-2516C591-D0C9-4FA5-9073-F149E505D32D

Q37036090-4F0E25AA-74BF-48C4-AD28-0B8485D1FE2B

Q37036090-56B4187F-4E64-451C-8A91-0DE538F2CDE3

Q37036090-5E34C0C2-AF82-448F-A962-926259D68081

Q37036090-68C86D1F-597A-450D-89B6-FDF9BB7042E3

Q37036090-74A349E5-1EC2-40DC-A687-5B440BD5F282

Q37036090-7C241B56-4893-46F5-BCBD-820743BDA659

Q37036090-C3695767-8FFC-4BD9-A09B-3E1C79B77B1C

P2860

Q37036090-050466E7-0FE7-47C4-B289-E7860583DB60

Q37036090-11A5E6A2-3CB8-4E8B-AFD3-C111BEE1BE65

Q37036090-14753A0C-6FED-4C33-BDD5-4C3144197D64

Q37036090-158EBF8D-2D0E-4142-9821-CB44B9ACA4A3

Q37036090-182F1290-94A7-445A-AF6C-61435D35805C

Q37036090-1EA1AFB9-E2FC-43E2-AACD-596B92552302

Q37036090-1FAC0193-202B-4191-8532-8F30ACB23367

Q37036090-23B94176-738E-41BD-80AC-0152010E5A81

Q37036090-290FD28D-AF0B-4516-AAA3-5AF34D3221A2

Q37036090-2EA4F7FA-57D5-4190-8F0B-356B01A58208

P304

Q37036090-DBDA1A94-B5BA-4E97-B64D-A71CFB7D3EA9

P31

Q37036090-E26BFF60-D629-4A56-AAE2-9516A91CE3E2

P356

Q37036090-1703733B-3530-4964-8F2A-23FE7F6E2814

P407

Q37036090-C7F5810A-4E3A-4D29-A86D-19AE99BC2CFD

P433

Q37036090-E450ECCA-661D-4350-ABFF-8335BB6306C6

P478

Q37036090-4785715B-2E80-42B6-9577-2DEEB1035ADB

P50

Q37036090-22CAFAE9-D21D-4BA4-A9BF-BF54A9E8A21C

Q37036090-CB82A9D2-91A1-4C77-86F8-897558BC40C2

P577

Q37036090-8E6A3A74-04FB-4E04-A68D-571C83392B57

P698

Q37036090-D8DE3834-F3E0-4230-B7D3-946F32F38D2F

P921

Q37036090-0A4A0DFE-08C3-4DA3-A6D8-41E376771AC3

Q37036090-684ED2F8-505F-40E3-BBAF-61D435C9E4E9

P932

Q37036090-628D0D55-C0C2-419A-A09E-920782169586

P356

P1433

Journal of Clinical Investigation

P1476

Infiltration of CD4+ lymphocyt ...... use model of Parkinson disease

@en

P2093

Aline Perrin

http://www.w3.org/2001/XMLSchema#string

Annick Prigent

http://www.w3.org/2001/XMLSchema#string

Béhazine Combadière

http://www.w3.org/2001/XMLSchema#string

Charles Duyckaerts

http://www.w3.org/2001/XMLSchema#string

Daniel Alvarez-Fischer

http://www.w3.org/2001/XMLSchema#string

Jacques Callebert

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Launay

http://www.w3.org/2001/XMLSchema#string

Olivia Bonduelle

http://www.w3.org/2001/XMLSchema#string

Richard A Flavell

http://www.w3.org/2001/XMLSchema#string

Vanessa Brochard

http://www.w3.org/2001/XMLSchema#string

P2860

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alpha

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses

Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

CD8 is needed for development of cytotoxic T cells but not helper T cells

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

Parkinson's disease: mechanisms and models

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

P304

182-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI36470

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Stéphane Hunot

Etienne C. Hirsch

P577

2008-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19104149

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2613467

http://www.w3.org/2001/XMLSchema#string